[Antibiotic resistance and biofilm formation in Pseudomonas aeruginosa strains isolated from patients with urinary tract infections].
Lenka Černohorská, Petra Sláviková
Abstract
Lenka Černohorská, Petra Sláviková
Abstract
Altogether 118 Pseudomonas aeruginosa strains isolated from urine of patients with urinary tract infection were tested by the disk diffusion method for susceptibility to ciprofloxacin, ofloxacin, gentamicin, amikacin, colistin, meropenem, imipenem, piperacillin/tazobactam and ceftazidime. All strains were also screened for biofilm formation using a modified Christensen method. Eighty-eight, i.e., 74.6%, of the tested strains were resistant to ofloxacin, 86 (72.9%) to ciprofloxacin and 70 (59.3%) to gentamicin. Forty strains (33.9%) were resistant to imipenem, 42 strains (35.6%) to meropenem, 14 strains (11.9%) to amikacin, 2 strains (1.7%) to colistin, 35 strains (29.7%) to piperacillin/tazobactam and 41 strains (34.7%) to ceftazidime. Co-resistance to ofloxacin, ciprofloxacin and gentamicin was detected in 67 strains (56.8%) while 12 strains (10.2%) were resistant to most tested antibiotics, with the exception of amikacin and colistin. Biofilm formation was found in 41 strains (34.7%), more precisely in 23 of 46 inpatient strains and 18 of 72 outpatient strains. Eight (66.6%) of 12 polyresistant strains were biofilm producers.
OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Altogether 118 Pseudomonas aeruginosa strains isolated from urine of patients with urinary tract infection were tested by the disk diffusion method for susceptibility to ciprofloxacin, ofloxacin, gentamicin, amikacin, colistin, meropenem, imipenem, piperacillin/tazobactam and ceftazidime. All strains were also screened for biofilm formation using a modified Christensen method. Eighty-eight, i.e., 74.6%, of the tested strains were resistant to ofloxacin, 86 (72.9%) to ciprofloxacin and 70 (59.3%) to gentamicin. Forty strains (33.9%) were resistant to imipenem, 42 strains (35.6%) to meropenem, 14 strains (11.9%) to amikacin, 2 strains (1.7%) to colistin, 35 strains (29.7%) to piperacillin/tazobactam and 41 strains (34.7%) to ceftazidime. Co-resistance to ofloxacin, ciprofloxacin and gentamicin was detected in 67 strains (56.8%) while 12 strains (10.2%) were resistant to most tested antibiotics, with the exception of amikacin and colistin. Biofilm formation was found in 41 strains (34.7%), more precisely in 23 of 46 inpatient strains and 18 of 72 outpatient strains. Eight (66.6%) of 12 polyresistant strains were biofilm producers.
Key concepts: Amikacin, Microbiology, Ceftazidime, Meropenem, Piperacillin, Imipenem, Gentamicin, Colistin